CRYVF Cryo-Save Group NV featured news, full reports, and detailed charts
Cryo-Save Group NV (CRYVF/CRYVF.PK) Wrap Up:
Cryo-Save Group N.V., a healthcare services group, operates as an adult stem cell storage company in Europe, the Middle East, India, and South Africa. The company operates laboratories for the processing and storage of human adult stem cell samples. It collects, processes, and stores hematopoietic stem cells (HSCs) collected from umbilical cord blood and mesenchymal stem cells (MSCs) collected from the umbilical cord itself at birth. It also offers CryoCord Gold, which consists of the collection and storage of the umbilical cord tissue itself containing MSCs, in addition to the HSCs taken from cord blood; and Cryo-Lip, which involves the collection and storage of fat tissue containing MSCs obtained via liposuction from adults. The company was formerly known as Life-Sciences Group N.V. and changed its name to Cryo-Save Group N.V. in May 2007. Cryo-Save Group N.V. was founded in 2000 and is based in Zutphen, the Netherlands.Cryo-Save Group NV (CRYVF:Pink OTC Markets Inc)
Snapshot of Cryo-Save Group NV (CRYVF)
|
OPEN
--
|
PREVIOUS CLOSE
$0.44
|
|
|
DAY HIGH
--
|
DAY LOW
--
|
|
|
52 WEEK HIGH
02/4/09 - $0.44
|
52 WEEK LOW
02/4/09 - $0.44
|
|
|
MARKET CAP
4.1M
|
AVERAGE VOLUME 3 mo
0.0
|
|
|
DILUTED EPS TTM
--
|
SHARES OUTSTANDING
9.2M
|
|
|
CRYVF Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
CRYVF Top Compensated Officers
Executives, Board Directors
Key developments for Cryo-Save Group NV (CRYVF)
Cryo-Save Group N.V. announced that Johan Goossens has been granted the title of Chairman of the Board of Directors, following the appointment of Marc Waeterschoot as Chief Executive in July.
Cryo-Save Group N.V., Special/Extraordinary Shareholders Meeting, Oct 05, 2009, at 13:00 CET-Central European. Location: IJsselpaviljoen, IJsselkade 1, 7201 HA Zutphen, Netherlands. Agenda: To consider Euronext Amsterdam listing and a proposed 5:1 share consolidation and redenomination.
Cryo-Save Group N.V. said that the company had various funding methods and is looking for acquisitions. The company also reported a 17% rise in its underlying first-half pretax profit. “The company wants to expand into Russia, Turkey and South America through acquisitions, partnerships or an expansion of its own operations,” Chief Financial Officer of Cryo-Save, Arnoud van Tulder said. “Acquisitions remain on our list. We are always looking,” Van Tulder said. The company said that it would finance the acquisition through its own funds, loans or via a share issue. The company said earlier this month it planned to list on Euronext Amsterdam in the fourth quarter. Cryo-Save reported underlying profit before tax of €2.1 million up 17% from €1.8 million in the same period last year.
CRYVF Competitors
| Company | Last | Change | |
| No competitor information is available for CRYVF. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | CRYVF | Industry Range |
| Price/Earnings | 100.0x |
|
| Price/Sales | 1,174.3x |
|
| Price/Book | 639.9x |
|
| Price/Cash Flow | 1,288.8x |
|
| TEV/Sales | 227.6x |
|
|
CRYVF |
||
CRYVF transactions
| Type Date |
Target |
|
Buyback
October 5, 2009 |
-- |
